Bioleaching Market Size 2021 | Is Projected to Reach USD 23 BN With 4.9% CAGR by 2027

The global Bioleaching market generated revenue of around USD 15 million in 2020 and anticipated to grow at a CAGR of over 4.9% during the forecast period from 2021 to 2027 to reach around USD 23 million in 2027.

Bioleaching (or biomining) is a mining and biohydrometallurgy (natural processes of interactions between microbes and minerals) method that uses microorganisms such as bacteria or archaea to extract precious metals from low-grade ore.

Acting as Economic alternative

Among the available mining technologies, bioleaching is becoming increasingly relevant. Bioleaching is no longer a promising technology, but rather an actual cost-effective treatment option for particular mineral ores.

A significant portion of today’s large-scale bioleaching operations are in developing countries. This situation is influenced by the fact that many developing countries have substantial mineral reserves, as well as the characteristics of bioleaching, which make it particularly suitable for developing countries due to its ease of use and low capital cost.

Download Free Sample PDF including full TOC, Tables and Figures@

New ways to finance mining

Novel funding and development models will become more popular as mining companies strive to reduce risk. Prices plummeted after China’s demand sparked a commodity boom in the first decade of the twenty-first century, forcing mining companies to concentrate on lowering debt levels and strengthening their balance sheets.

Alternative funding options, such as royalty and metal stream arrangements, have been established to relieve the financial strain on mining companies. These funding options are likely to continue to expand in order to spread the risk of new capital-intensive projects. Companies may also consider forming joint ventures, similar to those seen in the oil and gas industry, to limit their exposure to a specific project or jurisdiction, as well as service agreements.

Global Bioleaching Market by Type Insights

Copper, Biomining, and Iron are some of the major types of Bioleaching process. Biomining segment hold high value for the bioleaching market in 2020.

To Understand How Covid-19 Impact Is Covered in This Report – 

Global Bioleaching Market by Application Insights

Based on applications, global bioleaching market is bifurcated into mining and others. Mining has acquired larger portion of the market size of the global bioleaching market in 2020.

Global Bioleaching Market by Regional Insights

Asia Pacific had highest share in global market and is anticipated to continue over the forecast period. India has numerous opportunities as there is high scope for exploration of ironore, coal and bauxite. The overall rise can be attributed to the continuous investments and higher infrastructure projects.

Latin America has also become popular in the global market as there is explode in mineral exploration activities owing to higher investments in this sector. Countries like Peru and Chile have abundant copper and gold mines, which also resulted in greater global exploration of metals. Also, lenient mining regulation for overseas investors has contributed in the growth of the market.

Global Bioleaching Market Competitive Landscape

Most prominent players in the global Bioleaching market include Rio Tinto Plc, BacTech, Rio Algom Ltd, Freeport-McMoRan Copper and Gold Inc., Bindura Nickel Corporation, Teck Resources Ltd, BHP, Denison Mines Corp, Newmont Corporation, Nyrstar NV, and Anglo American. The report covers very detailed profiles of these key players.

Download Free Sample PDF including full TOC, Tables and Figures@


About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives.

Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
(US/CANADA) Ph.: +1-800-361-8290